My Memo, an Italian startup showcased at CES 2024, brings a fresh and stylish approach to automatic pill dispensers. Founded by Dr. Roee Dvir, the company addresses the challenge of medication adherence, particularly for chronic patients managing multiple medications.
Unlike traditional hospital-like pill dispensers, My Memo features a sleek and closed-box design, emphasizing user-friendliness and aesthetics. The device, supported by a mobile app, acts as a clinical diary, providing real-time notifications and alarms for both caregivers and patients. With additional sensors for temperature, humidity, GPS, and Bluetooth, My Memo aims to revolutionize medication management with a health-team approach.
“Revolutionizing Medication Adherence: My Memo’s User-Friendly Approach”
My Memo, developed by Italian startup RGF Diagnostics, introduces a user-friendly and stylish automatic pill dispenser to enhance medication adherence. Recognizing the prevalence of chronic patients managing multiple medications, the device aims to simplify the process with its compact and closed-box design. Unlike conventional hospital-like dispensers, My Memo’s aesthetic appeal enhances user experience. The accompanying mobile app serves as a clinical diary, offering real-time notifications to caregivers, medical professionals, and patients. By incorporating sensors for temperature, humidity, GPS, and Bluetooth, My Memo provides a comprehensive solution to medication management.
“Smart Medication Management: My Memo’s Health-Team Approach”
My Memo, a product of RGF Diagnostics, takes a health-team approach to medication management, combining autonomy for users with enhanced oversight for caregivers and medical professionals. Designed as the smallest footprint automatic pill dispenser, My Memo prioritizes accessibility and safety. The closed-box design prevents casual theft and ensures child safety. The accompanying mobile app functions as a clinical diary, offering real-time notifications and alarms. The device supports up to four medications, with the flexibility to add additional devices for users managing more than four medications, creating a comprehensive and user-centric solution.
“My Memo: Stylish and Functional Automatic Pill Dispenser Now Available in Europe”
My Memo, the innovative automatic pill dispenser from RGF Diagnostics, is making waves in Europe with its stylish and functional design. Developed by medical professionals who recognized the medication challenges faced by chronic patients, My Memo features a compact and closed-box design to enhance accessibility and safety. The accompanying mobile app serves as a clinical diary, offering real-time notifications for caregivers, medical professionals, and patients. With a focus on simplicity and aesthetics, My Memo is positioned to transform medication adherence and management for users managing multiple medications. FDA clearance is in progress for availability in the U.S., offering a reasonable price point with a $99 initiation fee and a $29 per month subscription.